Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) SHH
30.80
-1.02(-3.21%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
30.80
-1.02(-3.21%)
Currency In CNY
| Market Cap | 10.29B |
| Enterprise Value | 10.4B |
| P/E Ratio | 221.02 |
| PEG Ratio | 5.1 |
| Price/Sales Ratio | 16.13 |
| Price/Book Ratio | 13.41 |
| Enterprise/Revenue | 16.45 |
| Enterprise/EBITDA | 143.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.09 |
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
| Revenue | 704.16M |
| Revenue/Share | 1.91 |
| Gross Profit | 704.16M |
| EBITDA | 59.85M |
| Net Income | 22.23M |
| Diluted EPS | 0.05 |
| Total Cash | 194.9M |
| Total Cash/Share | 0.48 |
| Total Debt | 434.93M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 1.36 |
| Book Value Per Share | 2.3 |
| 52-Week Change | 70.83 |
| 52-Week High | 41.63 |
| 52-Week Low | 15.41 |
| Moving Average 50 Days | 32.4 |
| Moving Average 200 Days | 27.79 |
| Average Volume | 10.61M |
| Shares Outstanding | 405.71M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.14 |
| Last Split Factor | N/A |
| Last Split Date | N/A |